A5048750609- Lung Cancer Diagnosis and Treatment
- Lung Cancer Research Studies
- Myasthenia Gravis and Thymoma
- COVID-19 and healthcare impacts
- Cancer Immunotherapy and Biomarkers
- Surgical site infection prevention
- Lung Cancer Treatments and Mutations
- Pleural and Pulmonary Diseases
- Cancer Cells and Metastasis
Background: Circulating tumor cells (CTCs) play an important role in hematogenous metastasis of malignant tumors. Small cell lung cancer (SCLC) is the most aggressive form with highest number detected CTCs. Objective: To evaluate presence and CTCs as immunosuppression factor SCLC. Materials methods : In 30 patients stage III-IV SCLC, were using CellSearch system (Veridex LLC, Belgium) before treatment. The participants divided into groups based on Flow cytometry was used to assess T- natural...
Thymomas and carcinomas of the thymus gland, also known as epithelial tumors (TT) are rare malignant neoplasms, but most common solid anterior mediastinum. The incidence does not exceed 1.3–1.7 per million inhabitants year. In Europe, about 1,500 new cases registered annually, average age patients is around 40–50 years. Originating from component thymus, primary lymphoid organ, they accompanied by a high risk developing autoimmune disorders due to their unique biology. Indeed, up 30 % TETS...
Lung resection is the main diagnostic and therapeutic surgical intervention in terms of lung cancer management. Air leak through pleural drains often occurs after resections due to damage pulmonary parenchyma. Therefore, proper drainage cavity very important for successful outcome operation. The installation a single anatomical resection, refusal use vacuum aspiration earliest possible removal contribute rapid activation patients postoperative period. Prolonged air leakage (PAL) on average,...